Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2005
03/17/2005US20050059616 administering flavonoids and optionally vitamin E or excipients for the prophylaxis of bone or cardiovascular disorders, headaches, hypertension, cancers, leukemia, arteriosclerosis, Alzheimer's disease, inflammatory diseases, rheumatic diseases, acne, alopecia or psoriasis
03/17/2005US20050059606 hexapeptides including enantiomers, stereoisomers and tautomers, used as enzyme inhibitors for prophylaxis or prevention of viral diseases
03/17/2005US20050059108 Expression vector comprising nucleotide sequences coding neurotransmitter for use in prevention and treatment of obesity, anorexia, energy imbalance, diabetes, dyslipidemia, hypertension and/or insulin resistance
03/17/2005US20050059093 Method for detecting modulators of Notch signalling
03/17/2005US20050059008 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
03/17/2005US20050058732 Herbal pharmaceutical composition for treating siriasis and its process
03/17/2005DE10337863A1 Verwendung von Chromen-4-on-Derivaten The use of chromene-4-one derivatives
03/17/2005DE10016449B4 Verbessertes Verfahren zur Isolierung des hepatoprotektiven Mittels Silymarin aus den Samen der Pflanze Silybum marianum An improved process for the isolation of hepatoprotective agent silymarin from the seeds of the plant Silybum marianum
03/17/2005CA2549465A1 New salts of omeprazole and esomeprazole i
03/17/2005CA2537536A1 Process for the preparation of renzapride and intermediates thereof
03/17/2005CA2536934A1 Method for differentiating mesenchymal stem cell into hepatocyte and artificial human hepatocyte
03/17/2005CA2535983A1 New salts of omeprazole and esomeprazole ii
03/16/2005EP1514870A1 Prodrug and process for producing the same
03/16/2005EP1514869A1 Indole, indazole, and benzazole derivative
03/16/2005EP1514867A2 Substituted phenyl derivatives, their preparation and use
03/16/2005EP1514559A1 Arylpiperazines having activity at the serotonin 1a receptor
03/16/2005EP1514555A1 Polyherbal formulation for hepatic and splenic disorders
03/16/2005EP1514552A1 Novel fused imidazole derivative
03/16/2005EP1514545A1 Use of tolperisone for the treatment of spasms of organes consisting essentially of smooth muscles.
03/16/2005EP1514541A1 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
03/16/2005EP1513942A2 Galactosyl isomalt, method for production and use thereof
03/16/2005EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/16/2005EP1513842A1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines
03/16/2005EP1513839A1 3-substituted quinuclidines and their use
03/16/2005EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors
03/16/2005EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
03/16/2005EP1513831A1 Novel compounds, their use and preparation
03/16/2005EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
03/16/2005EP1513825A2 Anti tubercular drug: compositions and methods
03/16/2005EP1513820A2 Compounds, compositions, and methods
03/16/2005EP1513814A1 Novel piperidine compound
03/16/2005EP1513811A1 Non-peptidic brs-3 agonists
03/16/2005EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
03/16/2005EP1513809A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
03/16/2005EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors
03/16/2005EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1513560A2 Method of magnetically manipulating a cell with magnetisable particles
03/16/2005EP1513545A2 Methods and means to promote gut absorption
03/16/2005EP1513543A2 Fas peptide mimetics and uses thereof
03/16/2005EP1513536A1 Use of compounds that stimulate cgmp
03/16/2005EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
03/16/2005EP1513529A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain
03/16/2005EP1513527A1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
03/16/2005EP1513526A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1513525A1 Use of mglur5 antagonists for the treatment of gerd
03/16/2005EP1513518A1 Use of nefopam for the treatment of nausea or emesis
03/16/2005EP1513517A1 Formulation of nefopam and its use in the treatment of pain
03/16/2005EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES
03/16/2005EP1513511A1 (2s)-2-amino-4- [2-(ethanimidoylamino)ethyl]thio butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
03/16/2005EP1513495A1 Modified release pharmaceutical formulation
03/16/2005EP1513494A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
03/16/2005EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
03/16/2005EP1513416A1 Mammalian animal compositon
03/16/2005EP1513403A1 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
03/16/2005EP1392699B1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
03/16/2005EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
03/16/2005EP1117296B1 Combination of bisphosphonate and tetracycline
03/16/2005EP1003775B1 Hepatitis c inhibitor peptides
03/16/2005CN1596263A Aryl fused azapolycyclic compounds
03/16/2005CN1596257A Novel crystalline compound
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1596128A Pharmaceutical compositions of 5, 7, 14-triazatetracyclo[10.3.1.0(2, 11).0(4, 9)]-hexadeca-2(11)3, 5, 7, 9-pentaene
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596123A Interferon therapeutic effect-potentiating agents
03/16/2005CN1596122A Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
03/16/2005CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1596108A Aqueous ECABET sodium solution preparation
03/16/2005CN1594362A Yolk antibody specific for helicobacter pylori and its preparation and application
03/16/2005CN1594359A Hepatitis B vaccine and its preparation method
03/16/2005CN1594358A Method for reducing or inhibition of proliferation of oncogenic cells and compound used in it (variants)
03/16/2005CN1594354A Oleanolic acid couple derivatives and their pharmaceutical use
03/16/2005CN1594332A Glycyrrhetic acid and phospholipid composites of glycyrrhetate and process for preparing same
03/16/2005CN1593663A Target directional DNA vaccine for preventing caries and preparation method thereof
03/16/2005CN1593662A Target directional confluent DNA vaccine for preventing caries and preparation method thereof
03/16/2005CN1593654A Human lysozyme suppository, preparation method and application
03/16/2005CN1593653A Human lysozyme pellicle, preparation method and application
03/16/2005CN1593644A Medicine for treating liver disease and its preparing process
03/16/2005CN1593635A Orally disintegrating tablet of 'Huoxiang Zhengqi' and its preparation process
03/16/2005CN1593620A Detoxification Chinese medicine
03/16/2005CN1593618A Chinese medicinal powder with gall, giant knotweed, hyacinth bletilla and bornel
03/16/2005CN1593608A Medicinal powder with donkey hide and its preparation process
03/16/2005CN1593602A Injection for treating hepatitis B and its preparation
03/16/2005CN1593601A Chinese medicinal composition for cholecystitis and preparing method thereof
03/16/2005CN1593588A Prescription for instant treating gingival hemorrhage and its preparation method
03/16/2005CN1593586A Medicinal pill for treating hepatitis C and its preparing process
03/16/2005CN1593584A Novel formulation of 'Xiaoyan Lidan' and its preparation method
03/16/2005CN1593577A Tibetan medical liquor for nourishing kidney
03/16/2005CN1593575A Pure Chinese medicinal mixture with spleen benefiting, stomach strengthening, food retention removing and parasites killing function
03/16/2005CN1593563A Pharmaceutical composition and its preparation
03/16/2005CN1593559A Medicine for stopping pain of stomach intestine and preparation process thereof
03/16/2005CN1593557A Stomach intestine clearing capsule
03/16/2005CN1593549A Method for preparing compound medicinal capsule and powder for nourishing yin
03/16/2005CN1593548A Method for preparing compound medicinal liquor for nourishing yin
1 ... 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 ... 1258